Edge Rewrite
// HTMLRewriter · presentation

This page was redesigned at the edge.

Cloudflare fetched the original article and streamed it through HTMLRewriter to apply an entirely new visual system without rebuilding the source page.

Jump to content

Draft:Cambridge Economic Policy Associates

From Wikipedia, the free encyclopedia
  • Comment: In accordance with the Wikimedia Foundation's Terms of Use, I disclose that I have been paid by my employer for my contributions to this article. Economicconsultant2001 (talk) 08:57, 3 August 2026 (UTC)


Type: Private (Limited Company).[1]

  • Industry: Economic & Financial Consulting
  • Founded: 2001
  • Headquarters: London, UK
  • Other Offices: Sydney, Australia

Cambridge Economic Policy Associates (CEPA) is an international economic and financial policy advisory firm headquartered in London, United Kingdom. Founded in 2001, the firm specializes in advising public and private sector clients on matters where economics, finance, and public policy overlap. The firm operates global offices in Australia and India and is consistently ranked among the top economic consultancies in the United Kingdom.[2]

CEPA was founded by Keith Palmer (businessman) and David Newbery in 2001 as an economic consultancy business. The firm expanded over time to include an office in New Delhi in India in 2008 (now closed) and an office in Sydney in Australia in 2014. CEPA expanded from a UK economic consultancy into an international advisory firm with offices in London and Sydney, undertaking more than 1,200 projects for governments, regulators and infrastructure clients.

CEPA has advised regulators on economic regulation, competition policy, market design, cost of capital, infrastructure financing and public policy. There are several instances where CEPA work has become part of wider academic or policy discussion.

CEPA's Core Practice Areas are:

  • Regulation and Competition: Advising state utilities and communications regulators, such as Ofcom and Ofwat, on economic frameworks and price controls. This includes work on behalf of telecoms regulators in relation to spectrum, in transport in relation to Clean Air Zones[3], reports on Contracts for Difference (CfDs) for the UK Government[4] and a variety of work across public policy.[5][6][7][8][9]
  • Public Policy Strategy: Assessing government spending frameworks, including notable evaluations of the UK Treasury's Green Book appraisal process[10].
  • Global Health: Designing impact measurement metrics for international healthcare organizations and NGOs, with analysis published in The Lancet[11][12][13].

The firm has been independently recognized within the consulting sector, appearing in The Financial Times ranking of leading management consultants[14], and achieving "diamond level" placement by Consultancy UK as a top-five economics consultancy[15]

References

[edit]
  1. "CAMBRIDGE ECONOMIC POLICY ASSOCIATES LIMITED overview - Find and update company information - GOV.UK". find-and-update.company-information.service.gov.uk. Retrieved 2026-08-03.
  2. "Economics Matters". www.cepa.co.uk. Retrieved 2026-08-03.
  3. Barrett, Thomas. "City leaders call for £1.5bn funding to support national CAZ network - AirQualityNews". airqualitynews.com. Archived from the original on 2025-11-17. Retrieved 2026-08-03.
  4. Orlowski, Andrew (2012-05-23). "UK.gov energy policy: You can't please all the people much of the time". theregister. Retrieved 2026-08-03.
  5. Commission, Australian Competition and Consumer (2025-08-06). "Consultation". www.accc.gov.au. Retrieved 2026-08-03.
  6. "Sizewell C Economic Guidance | Ofgem". www.ofgem.gov.uk (in Welsh). 2025-08-20. Retrieved 2026-08-03.
  7. "Gavi second evaluation report". www.gavi.org. Retrieved 2026-08-03.
  8. "Periodic review 2008 (PR08) consultants' reports | Office of Rail and Road". www.orr.gov.uk. Retrieved 2026-08-03.
  9. "MD2397 Amendments to the Congestion Charge and Ultra Low Emission Zone | London City Hall". www.london.gov.uk. 2018-12-17. Retrieved 2026-08-03.
  10. "ABPI report warns Treasury Green Book undervalues life sciences manufacturing investments | News | LexisNexis". www.lexisnexis.co.uk. Retrieved 2026-08-03.
  11. Morin, Sébastien; Moak, Hannah Barron; Bubb-Humfryes, Oliver; Drehle, Christian von; Lazarus, Jeffrey V.; Burrone, Esteban (2022-02-01). "The economic and public health impact of intellectual property licensing of medicines for low-income and middle-income countries: a modelling study". The Lancet Public Health. 7 (2): e169–e176. doi:10.1016/S2468-2667(21)00202-4. ISSN 2468-2667. PMID 34710359.
  12. Christen, Paula; Audibert, Céline; Mulligan, Jo-Ann; Bubb-Humfryes, Oliver; Drehle, Christian von; Conteh, Lesong (2026-03-01). "Measuring the impact of global research and development investment in product development partnerships: a case study on return on investment in antimalarial drug development". The Lancet Global Health. 14 (3): e427–e434. doi:10.1016/S2214-109X(25)00456-5. ISSN 2214-109X. PMID 41713444.
  13. Boseley, Sarah (2011-06-06). "Q&A: Big pharma and the vaccine funding shortfall". The Guardian. ISSN 0261-3077. Retrieved 2026-08-03.
  14. "UK's Leading Management Consultants 2023: the ratings". 2023-02-17. Archived from the original on 2026-03-05. Retrieved 2026-08-03.
  15. "Top Economics consulting firms in the UK 2026". www.consultancy.uk. Retrieved 2026-08-03.